Article Text

Download PDFPDF
Randomised controlled trial
In children and adolescents with mild persistent asthma, daily beclomethasone reduces treatment failure compared with rescue beclomethasone plus albuterol
  1. Tom Kovesi
  1. Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada
  1. Correspondence to Tom Kovesi
    Department of Pediatrics, University of Ottawa, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada; kovesi{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlCrossRefPubMedWeb of Science


Many studies have shown that regular use of inhaled corticosteroids improves asthma control in children with asthma. However, intermittent therapy with inhaled corticosteroids is common practice in the community1 as many physicians and families are reluctant to administer inhaled corticosteroids long term. Several previous studies have examined this approach and have generally not found it to be convincingly effective. The investigators wished to evaluate the efficacy of this approach in children potentially ready to be ‘weaned off’ inhaled corticosteroids. Their findings add to the body of literature evaluating the efficacy of intermittent therapy with inhaled corticosteroids in children with mild, persistent asthma.


This was a large, multicentre, randomised, double-blind, placebo-controlled trial that employed a two-by-two factorial design. Between January 2007 and May 2009, the study enrolled children aged 6–18 years with a history mild, persistent asthma for the previous 2 years, who were felt to be eligible for ‘weaning’ …

View Full Text


  • Competing interests TK has received honoraria from AstraZeneca Canada, Nycomed Canada and Merck Frosst Canada.